Evidence mapPaperPMID 36979334Full record

ReviewBrain sciences2023

Somatic Cell Reprogramming for Nervous System Diseases: Techniques, Mechanisms, Potential Applications, and Challenges.

Jiafeng Chen, Lijuan Huang, Yue Yang, Wei Xu, Qingchun Qin, Rongxing Qin, Xiaojun Liang, Xinyu Lai, Xiaoying Huang, Minshan Xie and 1 more

Full text readReview
In one paragraph

Review in Brain sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Neural Correlates and Molecular Mechanisms of Memory and Learning.International journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jiafeng ChenDepartment of Neurology, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
Lijuan HuangDepartment of Neurology, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
Yue YangDepartment of Neurology, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
Wei XuDepartment of Neurology, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
Qingchun QinDepartment of Neurology, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
Rongxing QinDepartment of Neurology, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
Xiaojun LiangDepartment of Neurology, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
Xinyu LaiKey Laboratory of Longevity and Aging-Related Diseases of Chinese Ministry of Education, Nanning 530021, China.
Xiaoying HuangDepartment of Neurology, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
Minshan XieDepartment of Neurology, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
Li ChenDepartment of Neurology, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.ORCID 0000-0002-9478-6432

Funding

Advanced Innovation Teams and Xinghu Scholars Program of Guangxi Medical University YYZS2021002Guangxi Medical and Health appropriate Techology Development and Application Project S2021107National Natural Science Foundation of China 82260367National Natural Science Foundation of China 82271371
6 · The paper itself

Abstract

Nervous system diseases present significant challenges to the neuroscience community due to ethical and practical constraints that limit access to appropriate research materials. Somatic cell reprogramming has been proposed as a novel way to obtain neurons. Various emerging techniques have been used to reprogram mature and differentiated cells into neurons. This review provides an overview of somatic cell reprogramming for neurological research and therapy, focusing on neural reprogramming and generating different neural cell types. We examine the mechanisms involved in reprogramming and the challenges that arise. We herein summarize cell reprogramming strategies to generate neurons, including transcription factors, small molecules, and microRNAs, with a focus on different types of cells.. While reprogramming somatic cells into neurons holds the potential for understanding neurological diseases and developing therapeutic applications, its limitations and risks must be carefully considered. Here, we highlight the potential benefits of somatic cell reprogramming for neurological disease research and therapy. This review contributes to the field by providing a comprehensive overview of the various techniques used to generate neurons by cellular reprogramming and discussing their potential applications.

Indexed as

mechanismsmicroRNAmoleculesnervous system diseasesneuronsneurosciencereprogrammingsomatic celltherapeutictranscription factors

Identifiers

PMID36979334
PMCPMC10046178

What Socratic holds

Textfull text, public
LicenceCC BY
measurements read2
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.